Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment

BACKGROUND: Patients with renal impairment receiving classical anticoagulation for venous thromboembolism (VTE) are at increased risk of bleeding and possibly pulmonary embolism. We examined the efficacy and safety of oral rivaroxaban in patients with VTE with and without renal impairment. METHODS:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thromb J
Autori principali: Bauersachs, Rupert M, Lensing, Anthonie WA, Prins, Martin H, Kubitza, Dagmar, Pap, Ákos F, Decousus, Hervé, Beyer-Westendorf, Jan, Prandoni, Paolo
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Original Basic Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351845/
https://ncbi.nlm.nih.gov/pubmed/25750589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-12-25
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi